Nutrigenomics and nutrigenetics are new fields in medical sciences. They are concerned with studying the molecular mechanisms by which numerous dietary chemicals affect health and can modulate the risk of developing a disease on a particular genetic site, including combinations of variations in several genes. Over the past two decades, these two disciplines have been gaining momentum, with the most results currently being obtained by examining certain genetic variations, the single nucleotide polymorphisms (SNPs), which are a powerful molecular tool for studying the role of nutrition in human health and management of optimal diet conditions. Different nutrients and genome interact by suppressing / inducing the gene expression or by differences in the activity of receptors, enzymes, etc. involved in important metabolic pathways thus affecting the concentration of circulating substances and their metabolites, as well as the ability of nutrients to interact with individual genes. Clarification of these molecular mechanisms is essential for ad equate prophylaxis and increased treatment efficacy in a number of socially-significant diseases, such as type-2 diabetes mellitus, obesity, cardiovascular disease and some cancers.
Mutch DM, Wahli W, Williamson G. Nutrigenomics and nutrigenetics: the emerging faces of nutrition. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2005;19(12):1602-16.
h t t p : / / w w w. m e d i c i n e n e t . c o m / s c r i p t / m a i n / a r t . asp?articlekey=23241.
Ordovas JM, Mooser V. Nutrigenomics and nutrigenetics. Current opinion in lipidology. 2004;15(2):101-8.
Fenech M, El-Sohemy A, Cahill L, Ferguson LR, French TA, Tai ES, et al. Nutrigenetics and nutrigenomics: viewpoints on the current status and applications in nutrition research and practice. Journal of nutrigenetics and nutrigenomics. 2011;4(2):69-89.
Ordovas JM, Corella D. Nutritional genomics. Annual review of genomics and human genetics. 2004;5:71-118.
Corella D, Ordovas JM. Nutrigenomics in cardiovascular medicine. Circulation Cardiovascular genetics. 2009;2(6):637-51.
Wilson PW. Assessing coronary heart disease risk with traditional and novel risk factors. Clinical cardiology. 2004;27(6 Suppl 3):III7-11.
Lindner JR. Molecular imaging of cardiovascular disease with contrast-enhanced ultrasonography. Nature reviews Cardiol¬ogy. 2009;6(7):475-81.
Jansen AC, van Wissen S, Defesche JC, Kastelein JJ. Phenotypic variability in familial hypercholesterolaemia: an update. Current opinion in lipidology. 2002;13(2):165-71.
Corella D, Ordovas JM. SINGLE NUCLEOTIDE POLYMORPHISMS THAT INFLUENCE LIPID METABOLISM: Interaction with Dietary Factors. Annual review of nutrition. 2005;25:341-90.
Lefevre M, Champagne CM, Tulley RT, Rood JC, Most MM. Individual variability in cardiovascular disease risk factor responses to low-fat and low-saturated-fat diets in men: body mass index, adiposity, and insulin resistance predict changes in LDL cholesterol. The American journal of clinical nutrition. 2005;82(5):957-63; quiz 1145-6.
Mitchell BD, McArdle PF, Shen H, Rampersaud E, Pollin TI, Bielak LF, et al. The genetic response to short-term interven¬tions affecting cardiovascular function: rationale and design of the Heredity and Phenotype Intervention (HAPI) Heart Study. American heart journal. 2008;155(5):823-8.
Keys A, Anderson JT, Grande F. Serum cholesterol response to changes in the diet: III. Differences among individuals. Me¬tabolism: clinical and experimental. 1965;14(7):766-75.
Paoloni-Giacobino A, Grimble R, Pichard C. Genetics and nutrition. Clin Nutr. 2003;22(5):429-35.
Trujillo E, Davis C, Milner J. Nutrigenomics, proteomics, metabolomics, and the practice of dietetics. Journal of the Ameri¬can Dietetic Association. 2006;106(3):403-13.
Farhud D, Zarif Yeganeh M. Nutrigenomics and nutrigenetics. Iranian journal of public health. 2010;39(4):1-14.
Ferguson LR. Nutrigenomics: integrating genomic approaches into nutrition research. Molecular diagnosis & therapy. 2006;10(2):101-8.
Lai CQ, Corella D, Demissie S, Cupples LA, Adiconis X, Zhu Y, et al. Dietary intake of n-6 fatty acids modulates effect of apo¬lipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size: the Framingham Heart Study. Circulation. 2006;113(17):2062-70.
Tong Y, Lin Y, Zhang Y, Yang J, Zhang Y, Liu H, et al. Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiol¬ogy (HuGE) review and meta-analysis. BMC medical genetics. 2009;10:15.
Cornelis MC, Qi L, Kraft P, Hu FB. TCF7L2, dietary carbohydrate, and risk of type 2 diabetes in US women. The American journal of clinical nutrition. 2009;89(4):1256-62.
Fisher E, Boeing H, Fritsche A, Doering F, Joost HG, Schulze MB. Whole-grain consumption and transcription factor-7-like 2 ( TCF7L2) rs7903146: gene-diet interaction in modulating type 2 diabetes risk. The British journal of nutrition. 2009;101(4):478-81.
Wu X, Jin L, Xiong M. Mutual information for testing gene-environment interaction. PloS one. 2009;4(2):e4578.
Ames BN, Elson-Schwab I, Silver EA. High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased K(m)): relevance to genetic disease and polymorphisms. The American journal of clinical nutrition. 2002;75(4):616-58.
Virgili F, Perozzi G. How does Nutrigenomics impact human health? IUBMB life. 2008;60(5):341-4.
El-Sohemy A. Nutrigenetics. Forum of nutrition. 2007;60:25-30.
Iacoviello L, Santimone I, Latella MC, de Gaetano G, Donati MB. Nutrigenomics: a case for the common soil between cardiovascular disease and cancer. Genes & nutrition. 2008;3(1):19-24.
Levesque L, Ozdemir V, Gremmen B, Godard B. Integrating anticipated nutrigenomics bioscience applications with ethical aspects. Omics: a journal of integrative biology. 2008;12(1):1-16.